Nonspecific Pain Post Traumatic Injury Enrolling by Invitation Phase 4 Trials for Celecoxib (DB00482)

IndicationStatusPhase
DBCOND0107330 (Nonspecific Pain Post Traumatic Injury)Enrolling by Invitation4
clinicaltrials.gov IdentifierTitlePurposeDrugs